Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations

The prevalence of obesity in Asia is of epidemic proportions, with an estimated 1 billion overweight/obese individuals in the region. The majority of patients with type 2 diabetes mellitus (T2DM) are overweight/obese, which increases the risk of cardiorenal outcomes in these patients; hence, sustain...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Metab J
Autors principals: Sheu, Wayne Huey-Herng, Chan, Siew Pheng, Matawaran, Bien J., Deerochanawong, Chaicharn, Mithal, Ambrish, Chan, Juliana, Suastika, Ketut, Khoo, Chin Meng, Nguyen, Huu Man, Linong, Ji, Luk, Andrea, Yoon, Kun-Ho
Format: Artigo
Idioma:Inglês
Publicat: Korean Diabetes Association 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043991/
https://ncbi.nlm.nih.gov/pubmed/32097996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2019.0208
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars